Home About Us Pipeline Partnerships Investors News & Events Careers Contact Us
S*BIO Vision | Background | S*BIO Management | Board of Directors | Scientific Advisory Board | Corporate Values
Clinical Trials
News & Press Releases | Participation in Events | Publications
Join Our Team | Career Opportunities

The best scientist is open to experience and begins with romance - the idea that anything is possible.
Ray Bradbury


2008 News & Press Releases


19 December 2008 - S*BIO Enters Research Collaboration with Tan Tock Seng Hospital for Therapeutic and Biomarker Evaluation of JAK2 Inhibitor SB1518

2 December 2008 - S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis

22 October 2008 - Preliminary Clinical Data Presented at the 20th EORTC-NCI-AACR Symposium on “Molecular Targets and Cancer Therapeutics” Demonstrate Superior Profile of S*BIO’s Novel Anti-Cancer Drug SB939

20 October 2008 - S*BIO Completes US$26 Million Equity Financing
18 September 2008 - S*BIO Initiates U.S. Phase I Clinical Trials of Oral JAK2 Inhibitor SB1518 for the Treatment of Hematological Malignancies
13 May 2008 - S*BIO Receives Orphan Drug Designation for JAK2 Inhibitor SB1518 for the Treatment of Myeloproliferative Disorders






Back to News

Back to top



Copyright © 2002-2011 S*BIO Pte Ltd. All rights reserved.